Seeking the “coronal view” for new-onset unmet needs in chronic thromboembolic pulmonary hypertension during the COVID-19 pandemic

Kaynakça (4)

1. Akay T, Sade LE, Bozbaş Ş, Hekimoğlu K, Okyay K, Gültekin B, et al. How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: Too many gray zones to be considered. Turk J Vasc Surg 2021;30:70-6
2. Skulstad H, Cosyns B, Popescu BA, Galderisi M, Salvo GD, Donal E, et al. COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel. Eur Heart J Cardiovasc Imaging 2020;21:592-8
3. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-ofthe-Art Review. J Am Coll Cardiol 2020;75:2950-73
4. Ryan JJ, Melendres-Groves L, Zamanian RT, Oudiz RJ, Chakinala M, Rosenzweig EB, et al. Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic. Pulm Circ 2020;10:2045894020920153.